Date Filer Title Filing Type Shares Traded Price Total Held
Aug 17, 2021
Mamuszka Hannah
Director
Trans History: 9
 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 40,751 -- 40,751
Aug 17, 2021
TWOMEY CHRISTOPHER J
Director
Trans History: 14
 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 40,751 -- 40,751
Aug 17, 2021
Vuori Kristiina MD
Director
Trans History: 8
 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 40,751 -- 40,751
Sep 18, 2023
Chaubey Alka
Chief Medical Officer
Trans History: 12
 Chief Medical Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 40,000 -- 40,000
Sep 18, 2023
OLDAKOWSKI MARK
Chief Operating Officer
Trans History: 19
 Chief Operating Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 40,000 -- 40,000
Mar 06, 2023
Dixon Jonathan V.
General Counsel
Trans History: 4
 General Counsel Form 3 Initial Statement of Beneficial Ownership of Securities -- -- 39,270
May 26, 2021
Stewart Christopher P.
Chief Financial Officer
Trans History: 14
 Chief Financial Officer Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 25,000 $0.56 33,000
Feb 15, 2024
Chaubey Alka
CHIEF MEDICAL OFFICER
Trans History: 12
 CHIEF MEDICAL OFFICER Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 1,081 $1.27 31,487
Jun 06, 2019
Vuori Kristiina MD
Director
Trans History: 8
 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 30,274 -- 30,274
Jan 18, 2019
Borodkin Mark
Chief Operating Officer
Trans History: 19
 Chief Operating Officer Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 6,000 -- 28,219

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.